Country: United Arab Emirates, Angola, Austria view allAustralia, Belgium, Brazil, Canada, Switzerland, China, Germany, Denmark, Finland, France, United Kingdom, Hungary, Indonesia, Israel, India, Italy, Japan, Kenya, South Korea, Liberia, Luxembourg, Moldova, Nigeria, New Zealand, Oman, Philippines, Russian Federation, Sweden, Singapore, Thailand, Turkey, Trinidad and Tobago, United States, Yemen, South Africa, Zimbabwe
Requirements: Requires iOS 4.0 or later. Compatible with iPhone, iPad, and iPod touch.
Review clinical information about HARVONI® (ledipasvir 90 mg/sofosbuvir 400 mg) tablets, including dosing, efficacy, and safety details with this InteractivePrescribing Information (Pl) app. This app provides the full content of the FDA-approved HARVONI Pl in an easy-to-navigate interactive format that helps healthcare professionals learn about HARVONI.This interactive Pl application is intended ...more
Review clinical information about HARVONI® (ledipasvir 90 mg/sofosbuvir 400 mg) tablets, including dosing, efficacy, and safety details with this Interactive Prescribing Information (Pl) app. This app provides the full content of the FDA-approved HARVONI Pl in an easy-to-navigate interactive format that helps healthcare professionals learn about HARVONI.
This interactive Pl application is intended for US healthcare professionals only.
To report suspected adverse reactions, contact Gilead Sciences, Inc. at 1-800-GILEAD-5 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatchless
